Changing delta hepatitis patient profile: A single center experience in Valencia region, Spain

Table 1 General characteristics (n = 70)

Demographic parameters		n (%)	Missing data, %
Sex, men		44 (62.9)	0
Country of birth by region			0
Spain		47 (67.1)
Eastern Europe		17 (24.3)
Other		6 (8.6)
Probable route of infection			0
Unknown		32 (45.7)
Iatrogenesis		14 (20.9)
Intravenous drug use		10 (14.9)
Household contact		6 (8.6)
Sexual intercourse		4 (5.7)
Blood transfusion		2 (2.9)
Other		2 (2.9)
Diabetes mellitus	Non-diabetic	64 (91.4)	0
Alcohol consumption		24 (34.3)	1.42
Weight			8.7
Underweight		2 (2.9)
Normal weight		26 (37.1)
Overweight		23 (32.9)
Obese		12 (17.2)
Serologic parameters
HBe antigen	HBeAg+	8 (11.4)	1.4
HIV	Anti-HIV-IgG +	7 (10)	5.7
HCV	Anti-HCV-IgG +	8 (11.4)	0
Events
Progression to cirrhosis		54 (77.1)	1.4
Liver decompensation		39 (72.2)	7.4
Most frequent type of liver decompensation
Ascites		27 (71.1)
Upper gastrointestinal bleeding		10 (26.3)
Liver encephalopathy		1 (2.6)
Hepatorenal syndrome		0 (0)
Liver cancer		9 (12.9)	0
Liver transplant		32 (45.7)	0
Death		4 (5.7)	0

HBe: Hepatitis B e; HCV: Hepatitis C virus; HIV: Human immunodeficiency virus.